- Report
- May 2024
- 194 Pages
Global
From €3205EUR$3,374USD£2,757GBP
€3562EUR$3,749USD£3,064GBP
- Conference
- September 2024
- 2 Days
Global
€1322EUR$1,441USD£1,099GBP
€1563EUR$1,703USD£1,299GBP
- Conference
- September 2024
- 4 Days
Global
€1322EUR$1,441USD£1,099GBP
€1563EUR$1,703USD£1,299GBP
- Conference
- November 2024
- 2 Days
Europe
€1322EUR$1,441USD£1,099GBP
€1563EUR$1,703USD£1,299GBP
- Conference
- July 2024
- 2 Days
Europe
€1322EUR$1,441USD£1,099GBP
€1563EUR$1,703USD£1,299GBP
- Newsletter
- May 2024
- 4 Pages
Global
From €190EUR$200USD£163GBP
- Webinar
- November 2019
- 90 Minutes
Global
- Book
- December 2012
- 600 Pages
- Book
- July 2009
- 1248 Pages
- Book
- September 2009
- 296 Pages
The Adverse Event Reporting (AER) market is a subset of the clinical trial industry, focused on the collection and analysis of data related to adverse events. AER is a critical component of clinical trials, as it helps to identify potential safety issues and ensure the safety of trial participants. AER systems are used to collect, store, and analyze data related to adverse events, and to report this data to regulatory authorities. AER systems are also used to monitor the safety of drugs and medical devices throughout the clinical trial process.
AER systems are typically provided by specialized vendors, who offer a range of services, including software, data management, and consulting. These vendors typically provide a suite of products and services, including software, data management, and consulting.
Some companies in the AER market include Oracle, Medidata Solutions, eClinical Solutions, and Parexel. Show Less Read more